Preclinical drug evaluation, especially for cardiotoxicity, is a critical stage in the drug development process.

When used in this process, PhysioMimix allows for an earlier understanding of human safety profiles, the refinement of in vivo experimental design, and the de-risking of the drug development ...

A new fully automated in vivo screening system (AISS) has been developed to transform drug evaluation by enabling rapid, ...

A new fully automated in vivo screening system (AISS) has been developed to transform drug evaluation by enabling rapid, precise, and non-invasive ...

The field of cancer treatment has long struggled with the immense costs and time-consuming nature of drug development.

Scientists have identified a potential new benefit of a well-known drug: extending lifespan by improving mitophagy, the ...

Despite this remarkable progress, AI-powered drug design is still in its infancy ... of unpredictable pharmacologic and pharmacodynamic characteristics like in vivo half-life, tissue distribution and ...

New service integrates Biomimetic Chromatography and advanced data analytics to improve compound selection in early drug discovery ...